9.3 Bayesian and ML-driven DTRs: optimizing initiation, duration, and cessation In fertility management, the pivotal questions regarding GLP-1RAs are often not about efficacy in isolation, but rather the optimal timing of initiation, treatment duration, cessation, and sequencing with OI/ARTclassic Dynamic Treatment Regime (DTR) problems
employed a diet-induced NASH mouse model to compare the efficacy of cotadutide (a dual GLP-1/GCG agonist) against liraglutide (selective GLP-1 receptor agonist) and pair-fed controls
Beyond Weight Loss: The Full Spectrum of Benefits While weight loss gets the headlines, women with PCOS often experience even more meaningful improvements: More regular menstrual cycles : As insulin levels normalize, ovulation often becomes more predictable
Less common risks include gallbladder disease and, in rare cases, pancreatitis
Maljaars PW, Peters HP, Mela DJ, M AA
Tirzepatide: Dual-Receptor Action Tirzepatide activates two receptors simultaneously: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
